Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tanveer

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
IEEE Journal of Biomedical and Health Informatics|April 6, 2023
Redefining Lobe-Wise Ground-Glass Opacity in COVID-19 Through Deep Learning and its Correlation With Biochemical ParametersBudhadev Baral, Kartik Muduli, Shweta Jakhmola, et al.
Cureus|February 19, 2025
Efficacy, Safety, and Immunogenicity of Biosimilar Adalimumab Advixa® Compared With Reference Product Humira® in Patients With Rheumatoid Arthritis in BangladeshRowsan Ara, Syed Jamil Abdal, Md Ariful Islam, et al.
International Journal of Rheumatic Diseases|May 4, 2021
Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemicLai-Shan Tam, Yoshiya Tanaka, Rohini Handa, et al.
Rheumatology (Oxford, England)|September 26, 2024
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD datasetMarco Fornaro, Vincenzo Venerito, Maria Rosa Pellico, et al.
Open Research Europe|November 20, 2023
The state of the art in beyond 5G distributed massive multiple-input multiple-output communication system solutionsE Meyer, D Kruglov, M Krivic, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Rheumatology (Oxford, England)|April 2, 2023
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD studySasha Saadia Ali, Naveen R, Parikshit Sen, et al.
Rheumatology International|June 23, 2023
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD studyBohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
IEEE Journal of Biomedical and Health Informatics|April 6, 2023
Redefining Lobe-Wise Ground-Glass Opacity in COVID-19 Through Deep Learning and its Correlation With Biochemical ParametersBudhadev Baral, Kartik Muduli, Shweta Jakhmola, et al.
Cureus|February 19, 2025
Efficacy, Safety, and Immunogenicity of Biosimilar Adalimumab Advixa® Compared With Reference Product Humira® in Patients With Rheumatoid Arthritis in BangladeshRowsan Ara, Syed Jamil Abdal, Md Ariful Islam, et al.
International Journal of Rheumatic Diseases|May 4, 2021
Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemicLai-Shan Tam, Yoshiya Tanaka, Rohini Handa, et al.
Rheumatology (Oxford, England)|September 26, 2024
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD datasetMarco Fornaro, Vincenzo Venerito, Maria Rosa Pellico, et al.
Open Research Europe|November 20, 2023
The state of the art in beyond 5G distributed massive multiple-input multiple-output communication system solutionsE Meyer, D Kruglov, M Krivic, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Rheumatology (Oxford, England)|April 2, 2023
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD studySasha Saadia Ali, Naveen R, Parikshit Sen, et al.
Rheumatology International|June 23, 2023
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD studyBohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, et al.
Pageof 9